Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 6;6(1):243.
doi: 10.1186/s13643-017-0630-4.

Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes

Affiliations
Review

Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes

Bo Chen et al. Syst Rev. .

Abstract

Background: In meta-analyses (MA), effect estimates that are pooled together will often be heterogeneous. Determining how substantial heterogeneity is is an important aspect of MA.

Method: We consider how best to quantify heterogeneity in the context of individual participant data meta-analysis (IPD-MA) of binary data. Both two- and one-stage approaches are evaluated via simulation study. We consider conventional I 2 and R 2 statistics estimated via a two-stage approach and R 2 estimated via a one-stage approach. We propose a simulation-based intraclass correlation coefficient (ICC) adapted from Goldstein et al. to estimate the I 2, from the one-stage approach.

Results: Results show that when there is no effect modification, the estimated I 2 from the two-stage model is underestimated, while in the one-stage model, it is overestimated. In the presence of effect modification, the estimated I 2 from the one-stage model has better performance than that from the two-stage model when the prevalence of the outcome is high. The I 2 from the two-stage model is less sensitive to the strength of effect modification when the number of studies is large and prevalence is low.

Conclusions: The simulation-based I 2 based on a one-stage approach has better performance than the conventional I 2 based on a two-stage approach when there is strong effect modification with high prevalence.

Keywords: Heterogeneity; I 2; Individual participant data meta-analysis (IPD-MA); Two-stage and one-stage approaches.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
True τ 2 versus estimated τ 2. The estimated between-study variances from a conventional two-stage model and a simulation-based one-stage mode are compared with the true between-study variance
Fig. 2
Fig. 2
True τ 2 versus estimated I 2. The estimated I 2 from a conventional two-stage model and a simulation-based one-stage model are compared with the true between-study variance. The dashed line and dotted line represented the estimated I 2 from the two-stage and one-stage models based on its median value across 1000 datasets

Similar articles

Cited by

References

    1. Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5(14):14–14. doi: 10.1186/1471-2288-5-14. - DOI - PMC - PubMed
    1. What Is Meta-analysis? http://www.bandolier.org.uk/painres/download/whatis/Meta-An.pdf. Accessed 5 Mar 2016.
    1. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:521–5. doi: 10.1136/bmj.c221. - DOI - PubMed
    1. Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on i2 in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8(1):79. doi: 10.1186/1471-2288-8-79. - DOI - PMC - PubMed
    1. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi: 10.1002/sim.1186. - DOI - PubMed

Grants and funding